Alnylam Pharmaceuticals Current Deferred Revenue (Quarterly) Insights

Alnylam Pharmaceuticals, Inc. (ALNY)

396.45 -2.37 (-0.59%) USD | NASDAQ | Dec 30, 11:24

View Current Deferred Revenue (Quarterly) for ALNY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial